BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9043842)

  • 1. Prognostic value of plasma endothelin-1 in patients with chronic heart failure.
    Pousset F; Isnard R; Lechat P; Kalotka H; Carayon A; Maistre G; Escolano S; Thomas D; Komajda M
    Eur Heart J; 1997 Feb; 18(2):254-8. PubMed ID: 9043842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure.
    Isnard R; Pousset F; Trochu J; Chafirovskaïa O; Carayon A; Golmard J; Lechat P; Thomas D; Bouhour J; Komajda M
    Am J Cardiol; 2000 Aug; 86(4):417-21. PubMed ID: 10946035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure.
    Pacher R; Stanek B; Hülsmann M; Koller-Strametz J; Berger R; Schuller M; Hartter E; Ogris E; Frey B; Heinz G; Maurer G
    J Am Coll Cardiol; 1996 Mar; 27(3):633-41. PubMed ID: 8606275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levels of adrenomedullin in plasma of patients with chronic congestive heart failure].
    Halawa B; Mazurek W
    Pol Arch Med Wewn; 1998 Jan; 99(1):2-8. PubMed ID: 9686497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure.
    Pousset F; Masson F; Chavirovskaia O; Isnard R; Carayon A; Golmard JL; Lechat P; Thomas D; Komajda M
    Eur Heart J; 2000 Jun; 21(12):1009-14. PubMed ID: 10901513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of big endothelin-1 and endothelin-1 over natriuretic peptides in predicting survival in severe congestive heart failure: a 7-year follow-up study.
    Van Beneden R; Gurné O; Selvais PL; Ahn SA; Robert AR; Ketelslegers JM; Pouleur HG; Rousseau MF
    J Card Fail; 2004 Dec; 10(6):490-5. PubMed ID: 15599839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of plasma catecholamines, plasma renin activity, and plasma atrial natriuretic peptide at rest and during exercise in congestive heart failure: comparison with clinical evaluation, ejection fraction, and exercise capacity.
    Madsen BK; Keller N; Christiansen E; Christensen NJ
    J Card Fail; 1995 Jun; 1(3):207-16. PubMed ID: 9420653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.
    Adlbrecht C; Hülsmann M; Strunk G; Berger R; Mörtl D; Struck J; Morgenthaler NG; Bergmann A; Jakowitsch J; Maurer G; Lang IM; Pacher R
    Eur J Heart Fail; 2009 Apr; 11(4):361-6. PubMed ID: 19190023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokines and remodeling of the heart in patients with congestive heart failure].
    Jołda-Mydłowska B; Salomon P
    Pol Arch Med Wewn; 2003 Jan; 109(1):23-33. PubMed ID: 12879763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of serum cytokines in patients with congestive heart failure.
    Orús J; Roig E; Perez-Villa F; Paré C; Azqueta M; Filella X; Heras M; Sanz G
    J Heart Lung Transplant; 2000 May; 19(5):419-25. PubMed ID: 10808148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease.
    Yeh JL; Hsu JH; Dai ZK; Liou SF; Chen IJ; Wu JR
    Int J Cardiol; 2005 Sep; 104(1):15-20. PubMed ID: 16055212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Mabuchi N; Hayashi M; Ohnishi M; Sawaki M; Fujii M; Horie H; Sugimoto Y; Kinoshita M
    Eur Heart J; 1999 Dec; 20(24):1799-807. PubMed ID: 10581138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma concentrations of endothelin in congestive heart failure in humans.
    Rodeheffer RJ; Lerman A; Heublein DM; Burnett JC
    Mayo Clin Proc; 1992 Aug; 67(8):719-24. PubMed ID: 1434909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
    J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.